Remote Smoking Cessation in Hospitalized Cardiac Patients

ConditionSmoking Cessation

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorUniversity of Vermont Medical Center

About this trial

The investigators are proposing to examine new strategies for helping patients hospitalized for an acute coronary event adhere to recommendations to quit smoking. The investigators are interested to see whether offering financial incentives for smoking cessation, combined with medications to ameliorate withdrawal, can significantly reduce smoking in a population for which continued smoking has disproportionately negative health effects. The proposed trial can provide significant knowledge for promoting adherence to smoking cessation guidelines in patients with cardiac disease

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Hospitalization for an acute coronary event which includes myocardial infarction or coronary revascularization (percutaneous intervention or coronary artery bypass)

live within 30 miles of UVMMC and are >18 years of age

Current cigarette smoker (defined as reporting any use of cigarettes in the week before admission and >5 cigarette/day on average over the past 3 months)

Disqualifiers

severe dementia/Alzheimer's disease

an active malignancy, excluding non-melanoma skin cancer or low-grade prostate cancer under active surveillance

exercise limiting vascular or neuromuscular disease

Non-English Speaking

Trial design

Design model

Parallel

Treatments tested in this trial

Financial Incentives (FI) and Nicotine Replacement Therapy (NRT)
Behavioral
: In the intervention condition, patients will receive both NRT plus a 12-week program of monetary incentives for verified smoking abstinence that will be implemented by our clinic staff

Treatment groups

50 Participants

are divided into 2 treatment groups

Group A: Control: Usual CareNo intervention 0 interventions

Group B: Intervention: Financial incentives and nicotine replacement therapy interventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Biochemical verification of smoking status

Assess the efficacy of combined FI+NRT vs. UC on biochemically verified smoking abstinence

Time frame

3 months

Secondary outcomes

Cardiovascular Fitness

Determine the effect of smoking status on changes in cardiovascular fitness (VO2peak).

Time frame

3 months

Other outcomes

Smoking Characteristics

Cigarettes per day (CPD) using timeline follow back methods

Time frame

3 months

Smoking Characteristics

Fagerstrom Test for Nicotine Dependence \[FTND\]

Time frame

3 months

Smoking Characteristics

Heaviness of Smoking Index (HSI)

Time frame

3 months

Smoking Characteristics

and the Minnesota Nicotine Withdrawal Scale

Time frame

3 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Vermont Medical Center

Lead sponsor

Source ClinicalTrials.gov

Apply now